Mylan announces expansion in Dublin and Galway
Published on: Thursday, 19 April 2012
Through Mylan’s annual investment of up to €76 million ($100 million) over the next five years, including funding for manufacturing and expanded research and development (R&D) capabilities, and support from the Irish government through IDA, Mylan will add more than 500 new positions to its Ireland-based workforce by 2016. Mylan currently employs about 700 people at its facilities in Ireland including Gerard Laboratories and Bioniche Pharma. It is currently the largest generics pharmaceutical manufacturer in Ireland and ranks among the leading generic and specialty pharmaceutical companies in the world, providing products to customers in approximately 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com.